Skip to content

Opening book details…

Can I read Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling on EtoBox?

Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling by Maria M. Posada; Bridget L. Morse; P. Kellie Turner; Palaniappan Kulanthaivel; Stephen D. Hall; Gemma L. Dickinson is a Medicine article available to read on EtoBox.

What is Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling about?

## Abstract Abemaciclib, a selective inhibitor of cyclin‐dependent kinases 4 and 6, is metabolized mainly by cytochrome P450 (CYP)3A4. Clinical studies were performed to assess the impact of strong inhibitor (clarithromycin) and inducer (rifampin) on the exposure of abemaciclib and active metabolites. A physiologically based pharmacokinetic (PBPK) model incorporating the metabolites was developed to predict the effect of other strong and moderate CYP3A4 inhibitors and inducers. Clarithromycin increased the area under the plasma concentration‐time curve (AUC) of abemaciclib and potency‐adjusted unbound active species 3.4‐fold and 2.5‐fold, respectively. Rifampin decreased corresponding exposures 95% and 77%, respectively. These changes influenced the fraction metabolized via CYP3A4 in the model. An absolute bioavailability study informed the hepatic and gastric availability. In vitro data and a human radiolabel study determined the fraction and rate of formation of the active metabolites as well as absorption‐related parameters. The predicted AUC ratios of potency‐adjusted unbound active species with rifampin and clarithromycin were within 0.7‐ and 1.25‐fold of those observed. The P

Who reads Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Maria M. Posada; Bridget L. Morse; P. Kellie Turner; Palaniappan Kulanthaivel; Stephen D. Hall; Gemma L. Dickinson
Publisher
Wiley
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by Maria M. Posada; Bridget L. Morse; P. Kellie Turner; Palaniappan Kulanthaivel; Stephen D. Hall; Gemma L. Dickinson

Browse all works by Maria M. Posada; Bridget L. Morse; P. Kellie Turner; Palaniappan Kulanthaivel; Stephen D. Hall; Gemma L. Dickinson